RSS   Newsletter   Contact   Advertise with us
Post Online Media

Osiris Therapeutics appoints R. Alberto Avendano as CMO

OsirisOsiris Therapeutics, a stem cell company, announced that it has appointed R. Alberto Avendano as the company’s chief medical officer (CMO).

Dr. Avendano brings to Osiris his expertise in medical education and communication, academic and industry clinical research, pharmacovigilance and regulatory affairs.

Article continues below

READ MORE Osiris Therapeutics elects Hans Klingemann to the board

Dr. Avendano received his license to practice medicine almost 30 years ago. From June 2013 until joining Osiris, he served as the Medical Director for Indivior Inc. (previously Reckitt Benckisser Pharmaceuticals).

Prior to joining Indivior, Dr. Avendano served in a variety of medical director and research positions, most recently as Associate Medical Director at EMD Serono, Inc.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy